106 results found.
          
SeaSpine Launches Mariner MIS Posterior Fixation System
SeaSpine commenced limited launch of the Mariner® MIS Posterior Fixation System.
SeaSpine Up +8% in 2Q19 on New Product Launches
SeaSpine reports 2Q19 revenue of USD $39.3MM, +8% vs. 2Q18.
SeaSpine Launches Shoreline RT Cervical Interbody with Reef Topography
SeaSpine commenced limited launch of the Shoreline RT™ Cervical Interbody Implant featuring Reef Topography™ for increased surface ar...
SeaSpine Launches Mariner Outrigger® Revision System
SeaSpine commenced limited launch of the Mariner® Outrigger® Revision System, an adjunct to Mariner Posterior Fixation.
SeaSpine Announces 20,000th NanoMetalene Implantation
SeaSpine marked the implantation of the 20,000th NanoMetalene® interbody device. 
SeaSpine Expands OsteoStrand DBM Fiber Portfolio
SeaSpine introduced a new integrated open-bore hydration syringe for OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers.
SeaSpine Launches Regatta Lateral System
SeaSpine commenced full launch of the Regatta® minimally invasive lateral interbody fusion system.
Implanet reports 2Q19 revenue of €1.9MM (USD $2.2MM), +8.4% vs. 2Q18
Implanet reports 2Q19 revenue of €1.9MM (USD $2.2MM), +8.4% vs. 2Q18, with 1H19 revenue of €3.8MM (USD $8.0MM), +5.2% vs. 1H18.
Implanet Books First Orders Supporting Kico Knee and SeaSpine Partnerships
Implanet received its first orders related to its distribution agreements with Kico Knee Innovation and SeaSpine....
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
SeaSpine Reports 1Q19 Revenue of $36.2MM, +9% vs. 1Q18
SeaSpine reports 1Q19 revenue of USD $36.2MM, +9% vs. 1Q18.
Orthopedic Industry Revenue Reaches $51 Billion in 2018
By Mike Evers Download Your Copies
Implanet Gains FDA Clearance for JAZZ Cap
Implanet received FDA 510(k) clearance to market JAZZ Cap® to secure screws in poor quality bone in vertebral fusion procedures.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
SeaSpine Reports 4Q18 Revenue of $38MM, +11.9% vs. 4Q17
SeaSpine reports 4Q18 revenue of USD $38MM, +11.9% vs. 4Q17, with 2018 full y...
SeaSpine, Implanet Form US Partnership with Jazz Spinal Devices
Implanet entered into a U.S. private label distribution agreement with SeaSpine covering the Jazz® portfolio of spi...
Kuros Biosciences to Supply SeaSpine with Bone Graft
Kuros Biosciences signed a private label agreement to supply bone graft material to SeaSpine, which will market the products as Osteo...
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical Report Preliminary 4Q18 and FY 2018 Results
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical reported preliminary 4Q18 and FY 2018 results.
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
SeaSpine Reports 3Q18 Revenue of $35.8MM, +12.9% vs. 3Q17
SeaSpine picks up momentum, posts 3Q18 revenue of US $35.8MM, +12.9% vs. 3Q17.
SeaSpine Prices $50MM Public Offering of Stock
SeaSpine closed its underwritten public offering of 3,250,000 shares of its common stock for US $15.50/share, for gross proceeds of ~$50.4MM.
SeaSpine Launches Regatta Lateral System
SeaSpine commenced limited launch of the Regatta™ lateral interbody fusion system.
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
Spine Market Growth Expected to Remain at 2%
By Carolyn LaWell Spine accounts for 18% of the orthopaedic industry’s overall revenue. In 2017, estimated sales of spine products (excluding biologics) exceeded $9 billion worldwide, an increase of 2.2% or $197 million vs. 2016, according to our estimates published in
SeaSpine 2Q18 Revenue +7% vs. 2Q17
SeaSpine announced 2Q18 revenue of US $36.4MM, +6.5% vs. 2Q17, and 1H18 revenue of $69.6MM, +5.3% vs. 1H17. Thi...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group